InfuSystem Holdings (INFU) Capital Expenditures (QoQ) (2010 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | InfuSystem Holdings | 188.77 Mn | 186.67 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.11% |
| Dec 31, 2025 | 3,275.95% |
| Sep 30, 2025 | -92.66% |
| Jun 30, 2025 | 247.74% |
| Mar 31, 2025 | 10.66% |
| Dec 31, 2024 | 50.72% |
| Sep 30, 2024 | -285.03% |
| Jun 30, 2024 | 338.03% |
| Mar 31, 2024 | 81.70% |
| Dec 31, 2023 | -213.54% |
| Sep 30, 2023 | 922.60% |
| Jun 30, 2023 | -44.16% |
| Mar 31, 2023 | -76.18% |
| Dec 31, 2022 | 141.12% |
| Sep 30, 2022 | 2,609.09% |
| Jun 30, 2022 | -153.66% |
| Mar 31, 2022 | -95.33% |
| Dec 31, 2021 | 478.45% |
| Sep 30, 2021 | -178.91% |
| Jun 30, 2021 | 635.00% |